IRADIMED CORP's ticker is IRMD and the CUSIP is 46266A109. A total of 61 filers reported holding IRADIMED CORP in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,265,077 | -6.5% | 28,512 | +0.6% | 0.00% | 0.0% |
| Q2 2023 | $1,352,665 | +14.5% | 28,334 | -5.6% | 0.00% | 0.0% |
| Q1 2023 | $1,181,051 | +38.9% | 30,014 | -0.1% | 0.00% | +33.3% |
| Q4 2022 | $850,115 | +41.0% | 30,050 | -0.6% | 0.00% | +50.0% |
| Q3 2022 | $603,000 | -43.0% | 30,224 | -2.9% | 0.00% | -33.3% |
| Q2 2022 | $1,057,000 | -25.9% | 31,135 | -2.1% | 0.00% | -25.0% |
| Q1 2022 | $1,427,000 | -6.5% | 31,819 | -3.7% | 0.00% | 0.0% |
| Q4 2021 | $1,527,000 | +27.5% | 33,039 | -7.4% | 0.00% | +33.3% |
| Q3 2021 | $1,198,000 | +12.8% | 35,674 | -1.2% | 0.00% | 0.0% |
| Q2 2021 | $1,062,000 | +6.5% | 36,110 | -6.6% | 0.00% | 0.0% |
| Q1 2021 | $997,000 | +17.0% | 38,673 | +3.5% | 0.00% | +50.0% |
| Q4 2020 | $852,000 | +5.2% | 37,372 | -1.3% | 0.00% | 0.0% |
| Q3 2020 | $810,000 | -10.5% | 37,882 | -2.9% | 0.00% | -33.3% |
| Q2 2020 | $905,000 | +5.2% | 39,015 | -3.3% | 0.00% | -25.0% |
| Q1 2020 | $860,000 | -11.9% | 40,328 | -3.4% | 0.00% | +33.3% |
| Q4 2019 | $976,000 | +8.4% | 41,741 | -2.6% | 0.00% | 0.0% |
| Q3 2019 | $900,000 | -10.1% | 42,848 | -12.5% | 0.00% | -25.0% |
| Q2 2019 | $1,001,000 | -30.6% | 48,957 | -4.7% | 0.00% | -33.3% |
| Q1 2019 | $1,442,000 | – | 51,351 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Riverwater Partners LLC | 11,931 | $566,365 | 0.45% |
| MASSMUTUAL TRUST CO FSB/ADV | 9 | $427 | 0.00% |